Research funder · United States
Alzheimer's Association
A non-profit American health organization which focuses Alzheimer's disease
- Grants since 2016
- 1 779
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 7 372
- Funded works, all time
- 14.6k
Grants
2024 · research · T-PEP
Optimization of Lead Compounds for the Disassembly of Toxic Tau Aggregates
Antje Willuweit · Priavoid Gmbh
2024 · research · CBIDR
Aging and Dementia Research and Training (ADRET) Program in Uganda
Francis Bajunirwe · Mbarara University of Science and Technology
2024 · research · ARCOM
Measuring and Improving the Quality of Community-Based Dementia Care
Dallas Seitz · University of Calgary
2024 · research · AARF
Investigating aberrant cellular mechanics as early event of tau pathology
Martha Foiani · University College London
2024 · research · AARG-D
A novel bispecific antibody targeting amyloid beta
Jose Henrique Ledo · Medical University of South Carolina
2024 · research · CBIDR
Building Capacity in Neuropathology in a Low- and Middle-Income Country
Claudia Suemoto · Universidade de São Paulo
2024 · research · AARG
Olfactory Training in Mild Cognitive Impairment
Jeffrey Motter · Columbia University
2024 · research · AARF-D
Role of cholesterol metabolism to microglia reactivity and tau spreading
Matheus Rodrigues · University of Pittsburgh
2024 · research · AARG
Cis proline kinase in the development and therapy of Alzheimer's disease
Chenxi Qiu · Beth Israel Deaconess Medical Center
2024 · research · AARF
Deciphering TDP-43 molecular signatures in LATE, AD and related dementias
Sandra O. Tomé · KU Leuven
2024 · research · ABA
Replacement of Peripheral APOE4 with APOE2: Effects on AD Pathology
Lance Johnson · University of Kentucky
2024 · research · HPE-ADRD
Understanding Disparities in Dementia Care Access and Quality
Emily O'Brien · Duke University
2024 · research · NIAP
Unveiling the Neurovascular Responses to Amyloid-Beta Antibodies
Wonjae Lee · Duke University
2024 · research · AARF-D
Exploring the Physiological and Pathological Functions of BRI2 in Neurons
Metin Yesiltepe · Rutgers Health
2024 · research · AARG
Neuroprotective Effects of "Hypothermia in a Syringe"
Sonja Broeer · Freie Universität Berlin
2024 · research · AARG-D
Dissecting Commissures' role in Neurodegeneration using Genetic Techniques
Carolina Ochoa-Rosales · Brainlat Institute
2024 · research · AARF
Proteomic signatures of cognitive resilience in excitatory cortical neurons
Lauren Fish · Regent University
2024 · research · AARG
The Role of APOE4 in Synaptic Mitochondrial Dysfunction
Kelly Stauch · University Of Nebraska University Medical Center
2024 · research · AARG
CODEX Trial
Stephen Choi · Sunnybrook Health Science Centre
2024 · research · ABA
Supplement to Novel mouse models to study the biology of APOE variant risk
Michael Sasner · Jackson Laboratory
2024 · research · AARG-D
Exploring the role of SEL1L-HRD1 ERAD in Alzheimer's Disease
Ling Qi · University of Virginia
2024 · research · AARF
Dynamic interplay of vascular injury and inflammation on AD progression
Julie Ottoy · Sunnybrook Research Institute
2024 · research · AARG
Investigating the Neurophysiologic Impact of Amyloid Removal Therapy in AD
Stephanie Buss · Beth Israel Deaconess Medical Center
2024 · research · NIAP
In Vivo Quantification of Entorhinal Cortex Layer II Along the AD Continuum
Yuto Uchida · Johns Hopkins University
2024 · research · AARF
Effect of Passive Amylin Immunotherapy on Amylin and Beta-Amyloid Plaque Burden in AD
Deepak Kotiya · University Of Kentucky Research Foundation
2024 · research · AARF
The impacts of postoperative delirium on AD progression
Chengcheng Song · Duke University
2024 · research · HPE-ADRD
Impact of Genetic and Ethnic Risk Factors on Early Imaging Biomarkers of AD
Stephanie Leal · University of California, Los Angeles
2024 · research · AACSF-D
Cardiometabolic Risk Factors and Lewy Body Disease Symptom Progression
Shellie-Anne Levy · University of Florida
2024 · research · T-PEP
Novel PREP Ligands as a Disease-Modifying Therapy for Tauopathies
Timo Myohanen · University of Helsinki
2024 · research · NIAP
Developing a mouse model of auditory dysfunction in Alzheimer’s Disease
Chris Rodgers · Emory University
2024 · research · AARF-D
Multimodal AI based Predictor of Alzheimer’s Disease (MAP-AD)
Apoorva Safai · University of Wisconsin System
2024 · research · AACSF
The Amygdala as Gateway and Gatekeeper to Lewy Body Co-pathology
David Fischer · Regent University
2024 · research · AARF-D
Myelin Loss and Cognitive Impairment Following SARS-CoV-2 Infection
Narlon Cassio Boa Sorte Silva · University of British Columbia
2024 · research · AARG
Novel AD Plasma Biomarker Machine Learning Analysis & Molecular Validation
Amy Tsurumi · Massachusetts General Hospital
2024 · research · NIAP
Genomic Link between Vascular Risk Factors and AD in Diverse Populations
Annie Lee · Columbia University Irving Medical Center
2024 · research · NIAP
Uncovering the Molecular Pathogenesis of Semantic Dementia
Malik Nassan · Northwestern University
2024 · research · IR-AND
PET imaging of neuroinflammation in dementia with Lewy bodies
Min-Jeong Kim · Stony Brook University
2024 · research · T-PEP
Phosphoediting as a Therapeutic Strategy in Tauopathies
Fleur Ferguson · University of California San Diego
2024 · research · AARG
The Impact of Metabolic Signatures of the MIND Diet on Brain Aging
Debora Melo Van Lent · The University of Texas at San Antonio Health Science Center
2024 · research · AARG-D
Minnesota American Indian Dementia Surveillance System
Genelle Lamont · University of Minnesota